Home/Dimension Bio/Cole Johnson, Ph.D.

CJ

Cole Johnson, Ph.D.

SVP, Corporate Development

Therapeutic Areas

Liver Failure Regenerative Medicine

Dimension Bio Pipeline

Drug	Indication	Phase
BioNidum-based Liver Therapeutic	Liver Failure (Acute-on-chronic)	Preclinical

Leadership Team at Dimension Bio

Caralynn Nowinski Collens, M.D.

Co-founder & CEO

Ramille Shah, Ph.D.

Co-founder, CSO, Head of Platform R&D

Larry Weinstein

SVP, Manufacturing & Operations

Rafal Witek, Ph.D.

VP, Translational R&D, Head of Liver Program

View full Dimension Bio profile